These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1831585)

  • 21. High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements?
    Schulz O; Mitrovic V; Schönburg M; Thormann J
    Am Heart J; 1999 May; 137(5):887-94. PubMed ID: 10220638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease.
    Stephan H; Kazmaier S; Hoeft A; Sonntag H
    Anesth Analg; 1994 Dec; 79(6):1059-65. PubMed ID: 7978427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of enoximone versus tobutamine in the treatment of low cardiac output after cardiac surgery].
    Lançon JP; Caillard B; Volot F; Obadia JF; Bock F
    Ann Fr Anesth Reanim; 1990; 9(3):289-94. PubMed ID: 2142589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of low dose enoximone for chronic congestive heart failure.
    Jessup M; Ulrich S; Samaha J; Helfer D
    Am J Cardiol; 1987 Aug; 60(5):80C-84C. PubMed ID: 2956875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enoximone, a new phosphodiesterase inhibitor: the spectrum of applications during heart surgery--a comparison with dobutamine].
    Boldt J; Kling D; Schuhmann E; Scheld HH; Hempelmann G
    Herz; 1988 Oct; 13(5):335-42. PubMed ID: 2972597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enoximone versus dopamine in patients being weaned from cardiopulmonary bypass.
    Birnbaum DE; Preuner JG; Gieseke R; Trenk D; Jaehnchen E
    Cardiology; 1990; 77 Suppl 3():34-41; discussion 62-7. PubMed ID: 2148278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute effect of enoximone and captopril in patients with heart failure].
    Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
    Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
    Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enoximone improves selection of candidates for urgent cardiac transplantation.
    Loisance D; Benvenuti C; Dubois Randé JL; Deleuze P; Castaigne A; Cachera JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S23-7. PubMed ID: 2145234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
    Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enoximone in the postoperative phase of heart surgery].
    Hachenberg T
    Z Kardiol; 1994; 83 Suppl 2():63-8. PubMed ID: 8091826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-pharmacologic aspects of therapy with enoximone].
    Trenk D; Jähnchen E
    Z Kardiol; 1994; 83 Suppl 2():7-14. PubMed ID: 8091828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of enoximone in chronic heart failure.
    Saborowski F; Peters P; Schneider M; Fehske W; Dieterich HA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new phosphodiesterase inhibitor enoximone in patients following cardiac surgery--pharmacokinetics and influence on parameters of coagulation.
    Boldt J; Kling D; Dieterich HA; Marck P; Hempelmann G
    Intensive Care Med; 1990; 16(1):54-9. PubMed ID: 2138182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of the phosphodiesterase inhibitor enoximone in comparison with dobutamine in esmolol-treated cardiac surgery patients.
    Boldt J; Kling D; Zickmann B; Dapper F; Hempelmann G
    Br J Anaesth; 1990 May; 64(5):611-6. PubMed ID: 1972334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.